IPAD-DB ID | D00087 |
Name | Bexarotene |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 2 4 H 2 8 O 2 |
Molecular Weight | 348.5 g/mol |
IUPAC Name | 4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid |
InChI | InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26) |
InChIKey | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
PubChem CID | 82146 |
DrugBank Accession Number | DB00307 |
CAS Registry Number | 153559-49-0 |
Molecular Weight(Computed by SwissADME) | 348.48 |
Hac(Computed by SwissADME) | 26 |
Volume(Computed by ADMETlab 2.0) | 394.48 |
Density(Computed by ADMETlab 2.0) | 0.883 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 3 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 19 |
Flexibility(Computed by ADMETlab 2.0) | 0.158 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.425 |
LogD(Computed by ADMETlab 2.0) | 4.74 |
logP(Computed by ADMETlab 2.0) | 6.85 |
TPSA(Computed by SwissADME) | 37.3 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 3 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -3.03 |
Lipinski(Computed by SwissADME) | 1 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 1 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.85 |